<DOC>
	<DOC>NCT01621945</DOC>
	<brief_summary>The main objective of the study is to estimate the proportion of children, born between the 06/04/2004 and the 17/004/2008, living around Neufchatel en Bray, vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (&gt;= 4), before the fourth dose of MenBvac and after: 6 weeks and one year after the fourth dose.</brief_summary>
	<brief_title>Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)</brief_title>
	<detailed_description />
	<criteria>children born between 06/04/2004 and 17/04/2008, living in Neufchatel en Bray,and Having participated to the first study, children who Have to be Vaccinated MenBVac® for the four times, parental authority(ies)assent. no parental authority(ies)assent, no blood sample, impossibility of fourth vaccination, children yet vaccinated or non eligible for vaccination.</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Neisseria meningitidis B:14, P1-7, 16</keyword>
	<keyword>Serum bactericidal activity</keyword>
	<keyword>OMV vaccine</keyword>
</DOC>